Fast Acting Insulin Aspart Compared with Insulin Aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study

This is a single-center randomized open label active-controlled crossover trial comparing efficacy and safety of fast acting insulin aspart (FA) (FIASP(®)) versus insulin aspart (IAsp) (NovoLog(®)) when used in the Medtronic 670G system in auto mode in patients with type 1 diabetes. Forty patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozer, Kerem, Cooper, Alison M., Ahn, Lily P., Waggonner, Cassidy R., Blevins, Thomas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994433/
https://www.ncbi.nlm.nih.gov/pubmed/33090016
http://dx.doi.org/10.1089/dia.2020.0500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994433/
https://www.ncbi.nlm.nih.gov/pubmed/33090016
http://dx.doi.org/10.1089/dia.2020.0500

Ejemplares similares